Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-000311
Filing Date
2023-05-02
Accepted
2023-05-02 16:09:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4512
  Complete submission text file 0001950047-23-000311.txt   6045
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Subject) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-06571 | Film No.: 23879004
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Williams David Michael (Reporting) CIK: 0001820958 (see all company filings)

Type: 144